Business Context and Reporting Period
This Form 8-K is filed by NanoVibronix, Inc. (trading symbol: NAOV) on July 19, 2023. The report addresses a listing compliance matter with The Nasdaq Stock Market LLC regarding the company's continued listing on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance status rather than financial performance metrics.
Material Changes
The material event reported is the resolution of a deficiency notice previously issued on May 25, 2023. The company had failed to meet Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2.5 million in stockholders' equity. On July 19, 2023, Nasdaq staff granted the company an extension to regain compliance.
Outlook, Risks, and Contingencies
- Compliance Deadline: The company has been granted an extension through November 20, 2023, to demonstrate compliance with the minimum stockholders' equity requirement.
- Risk of Delisting: Failure to meet the equity requirement by the November 20, 2023 deadline could result in delisting from the Nasdaq Capital Market.
- Management Commentary: The filing confirms the company presented a plan to regain compliance, which was accepted by the Nasdaq staff.
Investor Verification Checklist
- Verify the company's current stockholders' equity balance to assess progress toward the $2.5 million threshold.
- Monitor subsequent filings for updates on the compliance plan before the November 20, 2023 deadline.
- Confirm the company's stock trading status on the Nasdaq Capital Market.
- Review the May 25, 2023 notification details for the full context of the initial deficiency.